Influence of receptor reserve on β-adrenoceptor-mediated responses in human lung mast

British Journal of Pharmacology

Volumn 124, Issue 4, 1998, Pages 711-718

  Drury, Duncan E J ^a   Chong, Lee K ^a   Ghahramani, Parviz ^a   Peachell, Peter T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

adrenoceptors; Desensitization; Mast cells; Receptor reserve

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BROMOACETYLALPRENOLOLMENTHANE; HISTAMINE; ISOPRENALINE; PROSTAGLANDIN E2; SALBUTAMOL;

ARTICLE; DOSE RESPONSE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALBUTEROL; ALPRENOLOL; ANTIBODIES, ANTI-IDIOTYPIC; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; ISOPROTERENOL; LUNG; MAST CELLS; RECEPTORS, ADRENERGIC, BETA;

EID: 0031806385     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701897     Document Type: Article

References (30)

1. ALI, H. & PEARCE, F.L. (1985). Isolation and properties of cardiac and other mast cells from the rat and guinea-pig. Agents Actions. 16, 138-140.
2. ASSEM, E.S.K. & SCHILD, H.O. (1969). Beta-adrenergic receptors concerned with the anaphylactic mechanism. Int. Archs Allergy Appl. Immunol., 45, 62-69.
3. BARNES, P.J. (1995). Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med., 152, 838-860.
4. BLAND, J.M. & ALTMAN, D.G. (1995). Multiple significance tests: the Bonferroni method. Br. Med. J., 310, 170.
5. BUTCHERS, P.R., SKIDMORE, I.F., VARDEY, C.J. & WHEELDON, A. (1980). Characterisation of the receptor mediating the anti-anaphylactic activities of β-adrenoceptor agonists in human lung tissue in vitro. Br. J. Pharmacol., 71, 663-667.
6. 2-adrenoceptor-mediated responses in human lung mast cells. Br. J. Pharmacol., 121, 717-722.
7. CHONG, L.K., MORICE, A.H., YEO, W.W., SCHLEIMER, R.P. & PEACHELL, P.T. (1995). Functional desensitization of β agonist responses in human lung mast cells. Am. J. Respir. Cell Mol. Biol., 13, 540-546.
8. CHURCH, M.K. &. HIROI, J. (1987). Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br. J. Pharmacol., 90, 421-429.
9. DULIS, B.H. & WILSON, I.B. (1980). The β-adrenergic receptor of live human polymorphonuclear leukocytes. J. Biol. Chem., 255, 1043-1048.
10. ENNIS, M. (1991). Current techniques of histamine determination. Automated fluorometric assays. Handbook Exp. Pharmacol., 97, 31-38.
11. FURCHGOTT, R.F. (1996). The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Advances Drug Res., 3, 21-55.
12. GILBERT, H.S. & ORNSTEIN, L. (1975). Basophil counting with a new staining method using Alcian Blue. Blood, 46, 279-282.
13. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol., 13, 25-33.
14. 2 adrenergic receptor structure. Pulmon. Pharmacol., 8, 1-10.
15. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry, 33, 9414-9419.
16. HAUSDORFF, W.P., CARON, M.G. & LEFKOWITZ, R.J. (1990). Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J., 4, 2881-2889.
17. HOYER, D. & BODDEKE, H.W.G.M. (1993). Partial agonists, full agonists, anatagonists: dilemmas of definition. Trends Pharmacol. Sci., 14, 270-275.
18. KENAKIN, T.P. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev., 36, 165-222.
19. 2-adrenoceptor. Mol. Pharmacol., 48, 316-325.
20. MAHAN, L.C. & INSEL, P.A. (1986). Expression of β-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response. Mol. Pharmacol., 29, 16-22.
21. MATTSON, H., HEDBERG, A. & CARLSSON, E. (1983). Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to β-adrenoceptor interaction in various tissues in vitro. J. Pharmacol. Exp. Ther., 224, 654-661.
22. MCPHERSON, G.A., MOLENAAR, P., MALTA, E. & RAPER, C. (1985). Influence of assay buffer on dissociation constants of drugs at β-adrenoceptor subtypes. Eur. J. Pharmacol., 119, 93-100.
23. 2-adrenergic receptors. Biochem. Pharmacol., 35, 857-864.
24. MINNEMAN, K.P., PUCKETT, A.M., JENSEN, A.D. & RINARD, G.A. (1983). Regional variation in β-adrenergic receptors in dog trachea: Correlation of receptor density and in vitro relaxation. J. Pharmacol. Exp. Ther., 226, 140-146.
25. ORANGE, R.P., AUSTEN, W.G. & AUSTEN, K.F. (1971). Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′5′-adenosine monophosphate. J. Exp. Med., 134, 136-148.
26. PEACHELL, P.T., MACGLASHAN, D.W., LICHTENSTEIN, L.M. & SCHLEIMER, R.P. (1988). Regulation of human basophil and lung mast cell function by cAMP. J. Immunol., 140, 571-579.
27. PEARCE, F.L. (1983). Mast cell heterogeneity. Trends Pharmacol. Sci., 4, 165-167.
28. SIRAGANIAN, R.P. (1974). An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem., 57, 283-287.
29. TATTERFIELD, A.E. (1992). Bronchodilators: new developments. Br. Med. Bull., 48, 51-64.
30. UNDEM, B.J., PEACHELL, P.T. & LICHTENSTEIN, L.M. (1988). Isoproterenol-induced inhibition of IgE-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. J. Pharmacol. Exp. Ther., 247, 209-217.